| Date Filed | Type | Description |
| 02/14/2023 |
4
| LOBELL J JAY (Director) has filed a Form 4 on Fortress Biotech, Inc.|
Txns:
| Bought 299,401 shares
@ $0.835, valued at
$250k
|
|
| 01/04/2023 |
4
| LOBELL J JAY (Director) has filed a Form 4 on Fortress Biotech, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 07/21/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/29/2022 |
4
| LOBELL J JAY (Director) has filed a Form 4 on Fortress Biotech, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 12/28/2021 |
4
| LOBELL J JAY (Director) has filed a Form 4 on PARDES BIOSCIENCES, INC.|
Txns:
| Granted 75,000 options to buy
@ $9.8, valued at
$735k
|
|
| 12/27/2021 |
3
| LOBELL J JAY (Director) has filed a Form 3 on PARDES BIOSCIENCES, INC. |
| 04/09/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/13/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/30/2018 |
4
| LOBELL J JAY (Director) has filed a Form 4 on Fortress Biotech, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 01/24/2017 |
4
| LOBELL J JAY (Director) has filed a Form 4 on Fortress Biotech, Inc. |
| 01/05/2016 |
4
| LOBELL J JAY (Director) has filed a Form 4 on Fortress Biotech, Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
| 03/16/2015 |
4
| LOBELL J JAY (Director) has filed a Form 4 on CORONADO BIOSCIENCES INC|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 02/24/2014 |
4
| LOBELL J JAY (Director) has filed a Form 4 on CORONADO BIOSCIENCES INC|
Txns:
| Granted 50,000 shares
@ $0 |
|
| 01/17/2014 |
4
| LOBELL J JAY (Director) has filed a Form 4 on CORONADO BIOSCIENCES INC|
Txns:
| Granted 30,000 options to buy
@ $2.1, valued at
$63k
|
|
| 08/22/2013 |
4
| LOBELL J JAY (Director) has filed a Form 4 on CORONADO BIOSCIENCES INC|
Txns:
| Bought 5,000 shares
@ $7.37, valued at
$36.9k
|
|
| 06/21/2013 |
4
| LOBELL J JAY (Director) has filed a Form 4 on CORONADO BIOSCIENCES INC|
Txns:
| Bought 10,000 shares
@ $7.6231, valued at
$76.2k
|
|
| 02/11/2013 |
4
| LOBELL J JAY (Director) has filed a Form 4 on CORONADO BIOSCIENCES INC|
Txns:
| Acquired 3,399 options to buy
@ $6.15, valued at
$20.9k
Granted 15,000 options to buy
@ $7.42, valued at
$111.3k
|
|
| 06/26/2012 |
4
| LOBELL J JAY (Director) has filed a Form 4 on CORONADO BIOSCIENCES INC|
Txns:
| Bought 25,000 shares
@ $5, valued at
$125k
|
|
| 02/14/2012 |
4
| LOBELL J JAY (Director) has filed a Form 4 on CORONADO BIOSCIENCES INC|
Txns:
| Granted 15,000 options to buy
@ $6.25, valued at
$93.8k
|
|
| 11/17/2011 |
4
| LOBELL J JAY (Director) has filed a Form 4 on CORONADO BIOSCIENCES INC|
Txns:
| Disposed of 17,878 options to buy
@ $6.15, valued at
$109.9k
Disposed of 3,337 options to buy
@ $6.15, valued at
$20.5k
Disposed of 5,960 options to buy
@ $6.15, valued at
$36.7k
|
|
| 09/13/2011 |
3
| LOBELL J JAY (Director) has filed a Form 3 on CORONADO BIOSCIENCES INC |
| 01/21/2009 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/30/2008 |
4
| LOBELL J JAY (Director) has filed a Form 4 on NOVADEL PHARMA INC |
| 12/17/2004 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 12/17/2004 |
SC 13G/A
| LOBELL J JAY reports a 0% stake in Cardiome Pharma. Corp. |
| 12/17/2004 |
SC 13G/A
| LOBELL J JAY reports a 1.5% stake in VioQuest Pharmaceuticals, Inc. |
| 12/17/2004 |
SC 13G/A
| LOBELL J JAY reports a 0.4% stake in Manhattan Pharmaceuticals, Inc. |
| 12/17/2004 |
SC 13G/A
| LOBELL J JAY reports a 0.8% stake in Point Therapeutics, Inc. |
| 03/31/2004 |
SC 13G/A
| LOBELL J JAY reports a 5.6% stake in Point Therapeutics, Inc. |
| 03/31/2004 |
SC 13G
| LOBELL J JAY reports a 4.8% stake in Point Therapeutics, Inc. |
| 02/17/2004 |
SC 13G/A
| LOBELL J JAY reports a 3.8% stake in Cardiome Pharma Corp. |
| 02/17/2004 |
SC 13G
| LOBELL J JAY reports a 16.8% stake in Chiral Quest, Inc. |
|